Europe — EMA

Palanossetrom Fresenius Kabi (Palonosetron Hydrochloride)

Palonosetron hydrochloride, the active ingredient in Palanossetrom Fresenius Kabi, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for intravenous use.

Palonosetron Hydrochloride

Request sourcing

Pack/s

What is Palonosetron Hydrochloride?

Palonosetron hydrochloride, the active ingredient in Palanossetrom Fresenius Kabi, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for intravenous use. It treats and prevents chemotherapy‑induced nausea and vomiting in adult oncology patients. GNH USA supplies Palanossetrom Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Palanossetrom Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Palonosetron Hydrochloride used for?

Palonosetron hydrochloride is ... ... ... ... ... ... ... ... ... .... … … … … … ....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →